Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Change in Receivables: 2023-2024

Historic Change in Receivables for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to -$381,000.

  • Inhibrx Biosciences' Change in Receivables rose 99.61% to -$3,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $728,000, marking a year-over-year increase of 2933.33%. This contributed to the annual value of -$381,000 for FY2024, which is 171.21% down from last year.
  • Per Inhibrx Biosciences' latest filing, its Change in Receivables stood at -$381,000 for FY2024, which was down 171.21% from $535,000 recorded in FY2023.
  • Inhibrx Biosciences' Change in Receivables' 5-year high stood at $535,000 during FY2023, with a 5-year trough of -$381,000 in FY2024.
  • In the last 2 years, Inhibrx Biosciences' Change in Receivables had a median value of $77,000 in 2023 and averaged $77,000.
  • Data for Inhibrx Biosciences' Change in Receivables shows a maximum YoY tumbled of 171.21% (in 2024) over the last 5 years.
  • Over the past 2 years, Inhibrx Biosciences' Change in Receivables (Yearly) stood at $535,000 in 2023, then plummeted by 171.21% to -$381,000 in 2024.